Pascal Mkanda

934 total citations
31 papers, 540 citations indexed

About

Pascal Mkanda is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Health. According to data from OpenAlex, Pascal Mkanda has authored 31 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 19 papers in Cardiology and Cardiovascular Medicine and 9 papers in Health. Recurrent topics in Pascal Mkanda's work include Viral Infections and Immunology Research (19 papers), Viral gastroenteritis research and epidemiology (16 papers) and Vaccine Coverage and Hesitancy (9 papers). Pascal Mkanda is often cited by papers focused on Viral Infections and Immunology Research (19 papers), Viral gastroenteritis research and epidemiology (16 papers) and Vaccine Coverage and Hesitancy (9 papers). Pascal Mkanda collaborates with scholars based in Republic of the Congo, United States and Nigeria. Pascal Mkanda's co-authors include Joseph Okeibunor, Richard Mihigo, Felicitas Zawaira, Peter Nsubuga, Richard Banda, Mark A. Pallansch, Rui G. Vaz, Alex Gasasira, John Vertefeuille and Cara C. Burns and has published in prestigious journals such as Science, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Pascal Mkanda

30 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Mkanda Republic of the Congo 14 321 266 173 118 75 31 540
Emmanuel Abanida Nigeria 11 280 0.9× 247 0.9× 181 1.0× 138 1.2× 64 0.9× 17 498
Eric Wiesen United States 15 317 1.0× 270 1.0× 152 0.9× 220 1.9× 38 0.5× 34 571
Richard Banda Nigeria 15 234 0.7× 153 0.6× 167 1.0× 138 1.2× 85 1.1× 39 523
Pascal Mkanda Republic of the Congo 12 224 0.7× 155 0.6× 123 0.7× 89 0.8× 61 0.8× 33 409
Stephanie Shendale Switzerland 11 235 0.7× 179 0.7× 185 1.1× 220 1.9× 45 0.6× 27 445
Arshad Quddus Switzerland 13 270 0.8× 255 1.0× 69 0.4× 125 1.1× 18 0.2× 17 468
Nalinee Sangrujee United States 13 264 0.8× 109 0.4× 99 0.6× 176 1.5× 36 0.5× 17 423
Margaret Watkins United States 11 207 0.6× 88 0.3× 333 1.9× 201 1.7× 80 1.1× 27 594
Sisay G. Tegegne Nigeria 11 143 0.4× 100 0.4× 71 0.4× 75 0.6× 52 0.7× 28 276
John W. Fitzsimmons United States 8 154 0.5× 96 0.4× 143 0.8× 135 1.1× 48 0.6× 10 398

Countries citing papers authored by Pascal Mkanda

Since Specialization
Citations

This map shows the geographic impact of Pascal Mkanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Mkanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Mkanda more than expected).

Fields of papers citing papers by Pascal Mkanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Mkanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Mkanda. The network helps show where Pascal Mkanda may publish in the future.

Co-authorship network of co-authors of Pascal Mkanda

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Mkanda. A scholar is included among the top collaborators of Pascal Mkanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Mkanda. Pascal Mkanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Umar, Abubakar, et al.. (2021). The Effect of Real Time Integrated Supportive Supervision Visits on the Performance of Health Workers in Zambia. PubMed. Special Issue(2). 120–126. 5 indexed citations
2.
Macklin, Grace, Kathleen O’Reilly, Nicholas C. Grassly, et al.. (2020). Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science. 368(6489). 401–405. 87 indexed citations
3.
Mihigo, Richard, Joseph Okeibunor, Balcha Masresha, et al.. (2018). IMMUNIZATION AND VACCINE DEVELOPMENT: Progress towards High and Equitable Immunization Coverage in the Africa Region from 2012 to 2016. PubMed. 2(SI1). 1–9. 20 indexed citations
4.
Bawa, Samuel, Fiona Braka, Akinola Ayoola Fatiregun, et al.. (2018). Lessons learnt from implementing community engagement interventions in mobile hard-to-reach (HTR) projects in Nigeria, 2014–2015. BMC Public Health. 18(S4). 1306–1306. 14 indexed citations
5.
Shuaib, Faisal, Sisay G. Tegegne, Fiona Braka, et al.. (2018). Acute flaccid paralysis (AFP) surveillance intensification for polio certification in Kaduna state, Nigeria: lessons learnt, 2015–2016. BMC Public Health. 18(S4). 1310–1310. 6 indexed citations
6.
Mihigo, Richard, et al.. (2017). Challenges of immunization in the African region. Pan African Medical Journal. 27(Suppl 3). 12–12. 50 indexed citations
7.
Mihigo, Richard, et al.. (2016). Investing in life saving vaccines to guarantee life of future generations in Africa. Vaccine. 34(48). 5827–5832. 18 indexed citations
8.
Vaz, Rui G., et al.. (2016). Public Health Innovations on the Way to Interruption of Poliovirus Transmission in Nigeria. The Journal of Infectious Diseases. 213(suppl 3). S65–S66. 6 indexed citations
9.
Verma, Harish, Zubairu Iliyasu, Pascal Mkanda, et al.. (2016). Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011–2014. The Journal of Infectious Diseases. 213(suppl 3). S124–S130. 10 indexed citations
10.
Gumede, Nicksy, Sheick Oumar Coulibaly, Ali Ahmed Yahaya, et al.. (2016). Polio Eradication Initiative (PEI) contribution in strengthening public health laboratories systems in the African region. Vaccine. 34(43). 5164–5169. 9 indexed citations
11.
Okeibunor, Joseph, et al.. (2016). Documentation of polio eradication initiative best practices: Experience from WHO African Region. Vaccine. 34(43). 5144–5149. 5 indexed citations
12.
Mkanda, Pascal, et al.. (2016). Strategic Engagement of Technical Surge Capacity for Intensified Polio Eradication Initiative in Nigeria, 2012–2015. The Journal of Infectious Diseases. 213(suppl 3). S116–S123. 13 indexed citations
13.
Ali, Daniel Ayalew, Richard Banda, Mohammed Abdulaziz, et al.. (2016). Strengthening Routine Immunization in Areas of Northern Nigeria at High Risk for Polio Transmission During 2012–2014. The Journal of Infectious Diseases. 213(suppl 3). S147–S150. 11 indexed citations
14.
Mkanda, Pascal, et al.. (2016). Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008–2015. The Journal of Infectious Diseases. 213(suppl 3). S101–S107. 9 indexed citations
15.
Mkanda, Pascal, Andrew Etsano, Charles Korir, et al.. (2016). Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013–2014. The Journal of Infectious Diseases. 213(suppl 3). S79–S85. 29 indexed citations
16.
Mkanda, Pascal, Richard Banda, Charles Korir, et al.. (2016). Revised Household-Based Microplanning in Polio Supplemental Immunization Activities in Kano State, Nigeria. 2013–2014. The Journal of Infectious Diseases. 213(suppl 3). S73–S78. 11 indexed citations
17.
Mkanda, Pascal, Frank Mahoney, John Vertefeuille, et al.. (2015). Mass immunization with inactivated polio vaccine in conflict zones – Experience from Borno and Yobe States, North-Eastern Nigeria. Journal of Public Health Policy. 37(1). 36–50. 15 indexed citations
18.
Ohuabunwo, Chima, Patrick Nguku, Ikechukwu U. Ogbuanu, et al.. (2014). Polio Eradication in Nigeria and the Role of the National Stop Transmission of Polio Program, 2012-2013. The Journal of Infectious Diseases. 210(suppl 1). S111–S117. 26 indexed citations
19.
Okayasu, Hiromasa, Alison Brown, Alex Gasasira, et al.. (2014). Cluster Lot Quality Assurance Sampling: Effect of Increasing the Number of Clusters on Classification Precision and Operational Feasibility. The Journal of Infectious Diseases. 210(suppl 1). S341–S346. 3 indexed citations
20.
Wassilak, Steven G. F., Muhammad Ali Pate, Kathleen Wannemuehler, et al.. (2011). Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population. The Journal of Infectious Diseases. 203(7). 898–909. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026